GN
Getinge AB (publ)
GNGBF · OTC
$25.00 +0.00% (+$0.00)
Market Cap 50.1B kr
P/E Ratio 18.76x
Div. Yield 2.57%
ROE 8.87%
Bulios Fair Price
$36.93
47.7% upside
Current Price
$25
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GNGBF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
86 /100
Cheap P/E 18.76x
EV/EBITDA 9.13x
P/S 1.47x
Growth
38 /100
Stable EPS growth 3.24%
Rev. growth 7.32%
FCF growth 5.70%
Profitability
67 /100
Strong Gross margin 47.79%
Net margin 7.82%
Op. margin 13.03%
Quality
41 /100
Average ROIC 6.79%
ROE 8.87%
ROA 4.66%
Debt
85 /100
Low Debt/Equity 0.36x
Current ratio 1.31x
Int. coverage 14.98x
Stability
87 /100
Stable Beta 0.83x
Rev. volatility 6.14%
EPS volatility 35.23%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GNGBF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Mattias Perjos
Employees
12,118
Headquarters
Gothenburg
Upcoming events
21 OCT
Earnings
Upcoming earnings report